Cargando…
Synthesis and Characterization of a Biomimetic Formulation of Clofazimine Hydrochloride Microcrystals for Parenteral Administration
Clofazimine (CFZ) is a broad spectrum antimycobacterial agent recommended by the World Health Organization as a first line treatment for leprosy and second line treatment for multidrug resistant tuberculosis. Oral administration of CFZ leads to a red skin pigmentation side effect. Since CFZ is a wea...
Autores principales: | Murashov, Mikhail D., Diaz-Espinosa, Jennifer, LaLone, Vernon, Tan, Joel W. Y., Laza, Raluca, Wang, Xueding, Stringer, Kathleen A., Rosania, Gus R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321048/ https://www.ncbi.nlm.nih.gov/pubmed/30453628 http://dx.doi.org/10.3390/pharmaceutics10040238 |
Ejemplares similares
-
Photoacoustic imaging of clofazimine hydrochloride nanoparticle accumulation in cancerous vs normal prostates
por: Tan, Joel W. Y., et al.
Publicado: (2019) -
Clofazimine-Mediated, Age-Related Changes in Skeletal Muscle Mitochondrial Metabolites
por: Diaz-Espinosa, Jennifer, et al.
Publicado: (2023) -
Distinguishing the Concentration- vs. Bioaccumulation-Dependent Immunological and Metabolic Effects of Clofazimine
por: Willmer, Andrew R., et al.
Publicado: (2023) -
Repositioning Clofazimine as a Macrophage-Targeting Photoacoustic Contrast Agent
por: Keswani, Rahul K., et al.
Publicado: (2016) -
Reverse Engineering the Intracellular Self-Assembly of a Functional Mechanopharmaceutical Device
por: Woldemichael, Tehetina, et al.
Publicado: (2018)